✦ LIBER ✦

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent

✍ Scribed by J. P. VAVALLE; C. P. RUSCONI; S. ZELENKOFSKE; W. A. WARGIN; J. H. ALEXANDER; R. C. BECKER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, repeat-dose, pharmacodynam

✍ M. Y. CHAN; C. P. RUSCONI; J. H. ALEXANDER; R. M. TONKENS; R. A. HARRINGTON; R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Dose Selection for a Direct and Selectiv

✍ T. J. Povsic; M. G. Cohen; M. Y. Chan; S. L. Zelenkofske; W. A. Wargin; R. A. Ha 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 277 KB

Phase 1 Single and Multiple Ascending Do

✍ Donovan, Joanne M.; Dunbar, Richard; Biernat, Lucasz; Logan, Douglas; Curtis, Mi 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 152 KB

2003 ANTIVIRAL ACTIVITY, PHARMACOKINETIC

✍ Gane, E.; Foster, G.R.; Cianciara, J.; Stedman, C.; Ryder, S.; Buti, M.; Clark, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Phase I dose-escalation study to examine

✍ Glen J. Weiss, Ross C. Donehower, Tara Iyengar, Ramesh K. Ramanathan, Karen Lewa 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 275 KB

Clinical trial: a multicentre, randomize

✍ C. PENA-ROSSI; S. SCHREIBER; G. GOLUBOVIC; A. MERTZ-NIELSEN; J. PANES; D. RACHMI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB